accruwebmaster

ACCRU-SC-2102

Treatment of Established Chemotherapy-Induced Neuropathy with N-Palmitoylethanolamide, a Cannabimimetic Nutraceutical: [...]

ACCRU-SC-2102accruwebmaster2022-07-19T14:08:03+00:00

Thyroid/Endocrine – Phase II Study of Cabozantinib in Patients with [...]

RU241210Iaccruwebmaster2022-03-08T13:48:14+00:00

Sarcoma – A Study of the Safety and Efficacy of [...]

MORAb-004-203-STSaccruwebmaster2022-03-08T13:48:54+00:00

Neuro Oncology – A Randomized Phase III Study of Temozolomide [...]

CE.6accruwebmaster2022-03-08T13:45:32+00:00

Melanoma – Randomized Phase II Study of AB (nab-paclitaxel Abraxane, [...]

RU261206Iaccruwebmaster2022-03-08T13:43:58+00:00

Open label, phase 2, single arm Study testing the combination [...]

ACCRU-MY-2101accruwebmaster2022-03-08T03:16:35+00:00

Open Label, Phase 2, Single-Arm Study of Selinexor, Daratumumab, Carfilzomib [...]

ACCRU-MY-1901accruwebmaster2022-07-14T15:55:31+00:00

Phase 2 Trial of Daratumumab Retreatment in Patients with Relapsed [...]

ACCRU-MY-1601accruwebmaster2022-03-08T03:14:02+00:00

A Phase II Trial of Oxaliplatin, Cytosine Arabinoside, Dexamethasone With [...]

MC0485accruwebmaster2022-03-08T03:02:07+00:00

Randomized Phase II Trial of Pentostatin, Cyclophosphamide, and Rituximab With [...]

RC0783accruwebmaster2022-03-08T02:58:53+00:00